HOUSTON--(BUSINESS WIRE)--Ensysce Biosciences Inc. announced today they have accomplished a $1 million dollar raise, part of which completes the Qualifying Financial Transaction milestone for the State of Texas Emerging Technology Fund (ETF). Funding of up to $1.5 million had previously been approved from the State ETF for the development of single walled carbon nanotube (SWCNT) therapeutics for the delivery of siRNA.
